Dashboard
Manage Tickers

BOLT Bolt Biotherapeutics, Inc.


$ 5.97 $ -0.48 (-7.44 %)    

Wednesday, 15-Oct-2025 14:57:54 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
$ 6.30
$ 5.55 x 100
$ 6.39 x 20
$ 5.97 - $ 6.30
$ 4.59 - $ 14.36
21,866
na
11.21M
$ -0.14
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
10/02/2025 17:06:31

fidus-investment-rocket-companies-and-other-big-stocks-moving-lower-in-thursdays-pre-market-session
Fidus Investment, Rocket Companies And Oth...
10/02/2025 12:45:54

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
10/02/2025 12:09:25

why-concorde-international-group-shares-are-trading-higher-by-55-here-are-20-stocks-moving-premarket
Why Concorde International Group Shares Ar...
10/02/2025 09:48:36

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
10/01/2025 21:05:58

bolt-biotherapeutics-says-initial-phase-1-bdc-4182-dose-escalation-data-now-expected-in-q3-2026-implements-50-workforce-cut
Bolt Biotherapeutics Says Initial Phase 1 ...
10/01/2025 20:06:16

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
08/28/2025 21:06:27

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
08/27/2025 12:08:39

bolt-biotherapeutics-q2-eps-446-beats-627-estimate-sales-180m-beat-81975k-estimate
Bolt Biotherapeutics Q2 EPS $(4.46) Beats ...
08/14/2025 20:41:07

Bolt Biotherapeutics (NASDAQ:BOLT) reported quarterly losses of $(4.46) per share which beat the analyst consensus estimate of ...

Core News & Articles
12 Health Care Stocks Moving In Friday's P...
08/01/2025 12:07:59

trading-halt-halted-at-75000-pm-et---trading-halt-halt-news-pending
Trading Halt: Halted at 7:50:00 p.m. ET - ...
06/06/2025 23:50:05

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
06/04/2025 21:05:56

bolt-biotherapeutics-to-effect-1-for-20-reverse-stock-split
Bolt Biotherapeutics To Effect 1-For-20 Re...
06/04/2025 20:11:43

-SEC Filing

lake-street-initiates-coverage-on-bolt-biotherapeutics-with-buy-rating-announces-price-target-of-4
Lake Street Initiates Coverage On Bolt Bio...
05/20/2025 14:36:43

Lake Street analyst Chad Messer initiates coverage on Bolt Biotherapeutics (NASDAQ:BOLT) with a Buy rating and announces Pri...

stifel-maintains-hold-on-bolt-biotherapeutics-lowers-price-target-to-1
Stifel Maintains Hold on Bolt Biotherapeut...
05/13/2025 16:25:01

Stifel analyst Stephen Willey maintains Bolt Biotherapeutics (NASDAQ:BOLT) with a Hold and lowers the price target from $1.2...

bolt-biotherapeutics-q1-eps-029-beats-036-estimate-sales-122m-beat-76750k-estimate
Bolt Biotherapeutics Q1 EPS $(0.29) Beats ...
05/12/2025 20:31:13

Bolt Biotherapeutics (NASDAQ:BOLT) reported quarterly losses of $(0.29) per share which beat the analyst consensus estimate of ...

bolt-biotherapeutics-announces-it-will-host-key-opinion-leader-conference-call-and-webcast-to-discuss-bdc-3042-phase-1-results-monday-may-12-2025-at-230-pm-pt--530-pm-et
Bolt Biotherapeutics Announces It Will Hos...
05/08/2025 12:08:54

Conference call and webcast on Monday, May 12, 2025, at 2:30 p.m. PT / 5:30 p.m. ET- Bolt Biotherapeutics (NASDAQ:BOLT), a biop...

bolt-biotherapeutics-presents-preclinical-results-from-next-generation-boltbody-isacs-targeting-ceacam5-and-pd-l1-at-aacr-annual-meeting
Bolt Biotherapeutics Presents Preclinical ...
04/30/2025 20:15:56

CEA-targeted ISAC elicits complete responses in mice and is well-tolerated in NHPsPD-L1 ISAC directly activates and reprograms ...

hc-wainwright--co-reiterates-neutral-on-bolt-biotherapeuticsto-neutral
HC Wainwright & Co. Reiterates Neutral on ...
03/25/2025 15:47:02

HC Wainwright & Co. analyst Edward White reiterates Bolt Biotherapeutics (NASDAQ:BOLT) from Neutral to Neutral.

stifel-maintains-hold-on-bolt-biotherapeutics-lowers-price-target-to-125
Stifel Maintains Hold on Bolt Biotherapeut...
03/25/2025 13:25:27

Stifel analyst Stephen Willey maintains Bolt Biotherapeutics (NASDAQ:BOLT) with a Hold and lowers the price target from $1.5...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION